Antihistamines: do they work? Further well-controlled trials involving larger samples are needed

被引:10
作者
Fumagalli, F [1 ]
Baiardini, I [1 ]
Pasquali, M [1 ]
Compalati, E [1 ]
Guerra, L [1 ]
Massacane, P [1 ]
Canonica, GW [1 ]
机构
[1] Univ Genoa, DIMI, Genoa, Italy
关键词
antihistamines; allergic inflammation; quality of life;
D O I
10.1111/j.1398-9995.2004.00573.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Histamine is one of the most important steps in the phlogistic allergic reaction. Its activity is due to the link to specific receptors on the cellular surface. HI-receptors of second generation are the most currently prescribed drugs in allergic diseases for their high selectivity, little or no central sedative effect, rapid onset of action and long half lives. Antihistamines can modulate part of immunological mechanisms involved in the pathogenesis of allergic inflammation reducing mediator release and expression of adhesion molecules, regulating the release of cytokines, chemokines and consequently inflammatory cells recruitment. The anti-inflammatory effects of cetirizine, desloratadine and levocetirizine are reviewed. Quality of life is considered too, as a main parameter in a global evaluation of the antihistamine's effects.
引用
收藏
页码:74 / 77
页数:4
相关论文
共 32 条
[21]   INHIBITORY EFFECT OF CETIRIZINE ON THE BRONCHIAL EOSINOPHIL RECRUITMENT INDUCED BY ALLERGEN INHALATION CHALLENGE IN ALLERGIC PATIENTS WITH ASTHMA [J].
REDIER, H ;
CHANEZ, P ;
DEVOS, C ;
RIFAI, N ;
CLAUZEL, AM ;
MICHEL, FB ;
GODARD, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (02) :215-224
[22]   Desloratadine in the treatment of chronic idiopathic urticaria [J].
Ring, J ;
Hein, R ;
Gauger, A .
ALLERGY, 2001, 56 :28-32
[23]  
Schipper H, 1990, Quality of life assessments in clinical trials, P11
[24]   Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine [J].
Schroeder, JT ;
Schleimer, RP ;
Lichtenstein, LM ;
Kreutner, W .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (09) :1369-1377
[25]   CETIRIZINE INHIBITS THE IN-VITRO AND EX-VIVO CHEMOTACTIC RESPONSE OF T-LYMPHOCYTES AND MONOCYTES [J].
TAN, JQ ;
REIMERT, CM ;
DELEURAN, B ;
ZACHARIAE, C ;
SIMONSEN, C ;
THESTRUPPEDERSEN, K .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (05) :979-986
[26]  
Thompson A, 1999, ANN ALLERG ASTHMA IM, V82, P122
[27]  
Thomson L., 2001, Allergy (Copenhagen), V56, P123
[28]  
Tosca M, 1998, J INVEST ALLERG CLIN, V8, P23
[29]   INHIBITORY ACTIVITY OF LORATADINE AND DESCARBOETHOXYLORATADINE ON EXPRESSION OF ICAM-1 AND HLA-DR BY NASAL EPITHELIAL-CELLS [J].
VIGNOLA, AM ;
CRAMPETTE, L ;
MONDAIN, M ;
SAUVERE, G ;
CZARLEWSKI, W ;
BOUSQUET, J ;
CAMPBELL, AM .
ALLERGY, 1995, 50 (03) :200-203
[30]   A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up [J].
Warner, JO .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (06) :929-937